Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
äŒæ¥ã³ãŒãAXGN
äŒç€ŸåAxoGen Inc
äžå Žæ¥Dec 17, 1986
æé«çµå¶è²¬ä»»è
ãCEOãDale (Michael Donald)
åŸæ¥å¡æ°451
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Dec 17
æ¬ç€Ÿæåšå°13631 Progress Blvd.
éœåžALACHUA
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·32615
é»è©±çªå·13864626817
ãŠã§ããµã€ãhttps://www.axogeninc.com/
äŒæ¥ã³ãŒãAXGN
äžå Žæ¥Dec 17, 1986
æé«çµå¶è²¬ä»»è
ãCEOãDale (Michael Donald)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã